← Open Payments lookup

KEESHA WYATT: Open Payments

NPI 1760994149 · ARLINGTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$456 in 26 payments from 12 companies in 2025. Trend: 2023 $635 · 2024 $169 · 2025 $456

Food & beverage: $456
CompanyPaymentsAmount
Novo Nordisk Inc4$71
GlaxoSmithKline, LLC.3$53
Lilly USA, LLC3$48
SANOFI-AVENTIS U.S. LLC2$46
Boehringer Ingelheim Pharmaceuticals, Inc.2$35
Bayer Healthcare Pharmaceuticals Inc.2$33
Kowa Pharmaceuticals America, Inc.2$32
Astellas Pharma US Inc2$32
AstraZeneca Pharmaceuticals LP2$32
Exact Sciences Corporation2$31

Products named: SHINGRIX, JARDIANCE, TZIELD, Ozempic, MOUNJARO, Kerendia, Rybelsus, ZORYVE.

Industry payments across TX — which companies pay providers there.